Abstract
Non-alcoholic fatty liver disease (NAFLD) is one of the most important causes of liver disease worldwide, with an estimated global prevalence of about 25%. Cirrhosis and hepatocellular carcinoma caused by this condition should soon become the main indication for liver transplantation (TF). The prevalence of comorbidities associated with metabolic syndrome is higher in NAFLD patients compa…